Cannabis Concentrate Regulations in New Mexico

Legal status overview

New Mexico legalized adult-use cannabis with the Cannabis Regulation Act (CRA), signed April 12, 2021 and effective June 29, 2021. Licensed adult-use retail sales began April 1, 2022 ^[1][2]. Concentrates — defined broadly to include extracts, resins, oils, waxes, and similar products — are legal cannabis products under the CRA when produced by a licensed cannabis manufacturer and sold by a licensed retailer ^[3].

Medical cannabis remains regulated separately under the Lynn and Erin Compassionate Use Act, originally passed in 2007, and enrolled patients retain distinct purchase rights and tax treatment ^[4].

This article is informational only and is not legal advice. Cannabis law in New Mexico is actively evolving; consult a licensed New Mexico attorney for advice on a specific situation.

Possession and purchase limits

Under NMSA 1978 § 26-2C-2 and CCD retail rules, an adult 21 or older may purchase in a single transaction up to:

• 2 ounces (56.7 g) of cannabis flower,
• 16 grams of cannabis extract (concentrate), and
• 800 milligrams of edible cannabis ^[1][3].

Possession limits in public mirror the per-transaction limits. Amounts above these thresholds, when possessed in public, can trigger civil or criminal penalties depending on quantity ^[1]. Within a private residence, adults may possess larger amounts, but quantities in excess of the public limits must be kept out of public view ^[1] Strong evidence.

Medical patients have separate allotments set by the Department of Health and CCD, generally allowing larger totals over a rolling period ^[4].

How concentrates can legally be made

Concentrate production is restricted to entities holding a Cannabis Manufacturer license issued by the CCD. The governing rules are in 16.8.4 NMAC (Cannabis Manufacturers) ^[3][5].

Key manufacturing requirements include:

• Approved extraction methods. Licensed manufacturers may use mechanical/solventless methods (e.g., ice water, rosin press), CO₂ extraction, ethanol extraction, and hydrocarbon extraction (butane, propane), but hydrocarbon and other volatile-solvent systems must use closed-loop equipment certified by a licensed professional engineer for the intended use ^[5] Strong evidence.
• Facility standards. Extraction rooms must meet local fire and building codes, including ventilation, gas detection, and electrical classification for hazardous locations where flammable solvents are used ^[5].
• Standard operating procedures. Manufacturers must maintain written SOPs for each extraction process and submit them as part of licensing ^[5].
• Testing. All concentrates must be tested by a CCD-licensed laboratory for potency (cannabinoids), residual solvents, pesticides, heavy metals, microbials, and mycotoxins before retail sale, per 16.8.7 NMAC (Cannabis Testing Laboratories) ^[6].

Home extraction with butane, propane, or other flammable/volatile solvents is prohibited. Solventless concentrates (e.g., kief, hash, rosin) made at home for personal use by adults 21+ are generally treated as personal cannabis production under the CRA's home-cultivation provisions, subject to the six-plant / twelve-plant-per-household cap ^[1] [evidence:weak — the statute is explicit on solvent extraction; solventless home processing is permitted by implication rather than by an express safe harbor].

Packaging, labeling, and potency disclosures

Concentrate packaging rules appear in 16.8.3 NMAC (Cannabis Retailers) and 16.8.4 NMAC. Requirements include ^[3][5]:

• Child-resistant, tamper-evident packaging at point of sale.
• Opaque or non-transparent exit packaging for products visible to minors.
• Labels stating cannabinoid content (THC and CBD by weight and per package), batch/lot number, manufacturer license number, date of manufacture, ingredients, allergens, and the New Mexico universal cannabis symbol.
• Warning statements about intoxication, pregnancy/breastfeeding, driving, and keeping out of reach of children.
• A prohibition on marketing designs appealing to minors (cartoons, imitation of mainstream candy branding, etc.).

Unlike some states (e.g., Vermont's 60% cap on concentrates), New Mexico does not currently impose a statutory THC potency cap on adult-use concentrates [evidence:strong — based on the absence of such a cap in the CRA and 16.8 NMAC as of the verification date].

Taxes and tracking

Adult-use concentrate sales are subject to the Cannabis Excise Tax under NMSA 1978 § 7-42-1 et seq. The rate began at 12% on April 1, 2022 and is scheduled to rise by one percentage point per year starting in 2025, reaching 18% in 2030, in addition to gross receipts tax ^[7]. Qualifying medical-patient purchases are exempt from the cannabis excise tax and from gross receipts tax ^[4][7].

All licensed producers, manufacturers, and retailers must use the state's seed-to-sale traceability system (operated by the CCD) to record every transfer of cannabis material, including extraction inputs and concentrate outputs ^[3] Strong evidence.

Public consumption, driving, and other restrictions

Even where concentrates are legally possessed, the CRA prohibits cannabis consumption (including vaporizing concentrate) in most public places. Consumption is restricted to private property or licensed Cannabis Consumption Areas, where local jurisdictions permit them ^[1][3].

New Mexico's impaired-driving statute, NMSA 1978 § 66-8-102, applies to cannabis impairment regardless of legal possession. There is no per-se THC blood limit in New Mexico; prosecution typically relies on officer observation and Drug Recognition Expert evaluation ^[8] Strong evidence.

Employers retain broad authority to maintain drug-free workplace policies; the CRA does not create a general right to use cannabis at work or to be free from employer testing ^[1] Strong evidence.

Recent and pending changes

Notable recent developments through the verification date:

• 2023 amendments to the CRA tightened CCD enforcement authority, including expanded license suspension and product-embargo powers in response to illicit-market diversion concerns ^[2].
• The CCD updated 16.8 NMAC rules in 2023 to clarify testing thresholds and labeling for inhalable concentrates (vape cartridges) ^[5][6].
• Ongoing legislative discussion of intoxicating hemp-derived cannabinoids (delta-8 THC, THC-O) — as of mid-2024, New Mexico had not enacted a comprehensive hemp-cannabinoid statute, leaving these products in a gray area outside the CCD framework Disputed.

Last verified: 2024-06-15. Confirm the current text of the Cannabis Regulation Act and 16.8 NMAC with the New Mexico Compilation Commission and the Cannabis Control Division before relying on any specific rule.

See also: Cannabis Concentrates Overview, Hydrocarbon Extraction Safety, State-by-State Cannabis Law.

Sources

How this page was made